Issue link: https://www.e-digitaleditions.com/i/1208415
Respiratory Drug Delivery (RDD®) 2020 will take place April 26-30 and be immediately followed by a symposium jointly presented by RDD and the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). 10 February 2020 Inhalation Image courtesy of the JW Marriott Desert Springs R espirator y Drug Deliver y (RDD ® ) 2020 will take place April 26-30 and be immediately followed by a symposium jointly presented by R DD and the International Pharmaceutical Aerosol Consor- tium on Regulation & Science (IPAC-RS). Session topics RDD presentation topics will be: Advances in difficult-to-treat pul- monary infections, Airway remod- eling or renovation? New DPI the- ory and practice, Clinically relevant testing in NDA and lifecycle sub- missions, Evaluating nasal drugs: improving topical and nose-to- brain delivery, Reducing our car- bon footprint, and Impact of new technology & regulation on inhaler design, development & product lifecycle. Platinum sponsors will host 30-minute presentations on new technologies and participants may attend two of the sessions. Highlights and awards The Charles G. Thiel Award for outstanding research and discov- ery in respiratory drug delivery and the VCU RDD Peter R. Byron Graduate Student Award will be presented. e conference will also include scientific posters and post- ers on the podium, a technology exhibition and a gala dinner on Wednesday, April 29. A preview of Respiratory Drug Delivery (RDD ® ) 2020 When? April 26-30, 2020 Where? Palm Desert, California, US For more information and registration: www.rddonline.com/rdd/rdd. php?id=18 Subscribe today at Inhalationmag.com